Clinical Responses to ERK Inhibition in BRAF V600e-Mutant Colorectal Cancer Predicted Using a Computational Model

npj Systems Biology and Applications - United Kingdom
doi 10.1038/s41540-017-0016-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

BRAF V600E Mutant Colorectal Cancer Subtypes Based on Gene Expression

Clinical Cancer Research
Cancer ResearchOncology
2016English

Immunohistochemical Detection of the BRAF V600E Mutant Protein in Colorectal Neoplasms

Applied Immunohistochemistry and Molecular Morphology
Forensic MedicinePathologyMedical Laboratory TechnologyHistology
2015English

Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF-Mutant Metastatic Colorectal Cancer Patients

Clinical Cancer Research
Cancer ResearchOncology
2015English

Comment on “ERK and P38MAPK Combine to Improve Survival in Patients With BRAF Mutant Colorectal Cancer”

British Journal of Cancer
Cancer ResearchOncology
2018English

Unresponsiveness of Colon Cancer to BRAF(V600E) Inhibition Through Feedback Activation of EGFR

Nature
Multidisciplinary
2012English

Redifferentiation of Iodine-Refractory BRAF V600e-Mutant Metastatic Papillary Thyroid Cancer With Dabrafenib

Clinical Cancer Research
Cancer ResearchOncology
2014English

Acquired Resistance to BRAF Inhibition in BRAFV600E Mutant Gliomas

Oncotarget
Oncology
2016English

Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer

Cancer Research
Cancer ResearchOncology
2016English

Distinct BRAF (V600E) and KRAS Mutations in High Microsatellite Instability Sporadic Colorectal Cancer in African Americans

Clinical Cancer Research
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy